Executives On The Move

The ex-GSK supply head Ian McCubbin will join the independent UK organization aimed at advancing cell and gene therapies, but notes issues with scale and manufacturing ahead.

C-suite changes at Omega Therapeutics and promotions at Cabaletta Bio are among recent executive changes in the industry. Meanwhile, new directors were appointed at AN2 Therapeutics, among others.

Recent executive changes in the industry include the appointment of a new vice president of human resources at aTyr Pharma and promotions at Zhejiang Shapuaisi Pharmaceutical. Meanwhile, new directors were appointed at GlaxoSmithKline and Dicerna Pharmaceuticals, among others.

A new secretary appointed at Genor Biopharma and promotions at Zai Lab are among recent executive changes in the industry. Meanwhile, new directors were appointed at Tenaya Therapeutics, among others.

Rajkumar Kannan now leads Aerie, while other changes include former Genentech exec Saraswati Kenkare-Mitra joining Alector as head of R&D and Theresa LaVallee, formerly of Celldex Therapeutics, joining Coherus BioSciences as chief development officer.

C-Suite changes at Iterium Therapeutics and promotions at Exicure are among recent executive changes in the industry. Meanwhile, new board members were appointed at Biofrontera, among others.

C-Suite changes at AbCellera Biologics and promotions at Lyell Immunopharma are among recent executive moves in the industry. Meanwhile, new directors were appointed at Decibel Therapeutics, Curis and Ventus Therapeutics, among others.

C-suite changes at Relief Therapeutics and promotions at Black Diamond Therapeutics are among recent executive changes in the industry. Meanwhile, new directors were appointed at Adagio Therapeutics, OKYO Pharma and Tenaya Therapeutics, among others.

C-suite changes at Appili Therapeutics and promotions at Collmune are among recent executive changes in the industry. Meanwhile, new directors were appointed at Diurnal Group, Artios Pharma and Verastem, among others.

C-suite changes at Acorda Therapeutics and promotions at GT Biopharma are among recent executive changes in the industry. Meanwhile, new directors were appointed at Caribou Bioscience, Defence Therapeutics and Beam Therapeutics, among others.

New leaders in investor relations at Johnson & Johnson and promotions at Vivanza Biosciences are among recent executive changes in the industry. Meanwhile, new directors were appointed at Bioventus and AC Immune, among others.

New leaders in regulatory and technology at Arcturus Therapeutics and promotions at Elevar Therapeutics are among recent executive changes in the industry. Meanwhile, new directors were appointed at Palette Life Sciences, BioVectra, Inc. and Allergy Therapeutics, among others.